FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096100859> ?p ?o ?g. }

• W2096100859 endingPage "1365" @default.
• W2096100859 startingPage "1360" @default.
• W2096100859 abstract "Pyrimethamine pharmacokinetics were studied in 11 human immunodeficiency virus (HIV)-positive patients who were seropositive for exposure to Toxoplasma gondii and were taking zidovudine (AIDS Clinical Trials Group Protocol 102). Pyrimethamine was administered at 50 mg daily for 3 weeks to achieve steady state, and pharmacokinetic profiles were determined after administration of the last dose. Noncompartmental and compartmental analyses were performed. Population pharmacokinetic analysis assuming a one-compartment model yielded the following estimates: area under the 24-h concentration-time curve, 42.7 +/- 12.3 micrograms.h/ml; halflife, 139 +/- 34 h; clearance, 1.28 +/- 0.41 liters/h; volume of distribution, 246 +/- 641; and absorption rate constant, 1.5 +/- 1.3 liters/h. These values are similar to those seen in subjects without HIV infection. Pyrimethamine pharmacokinetics did not differ significantly in those subjects who were intravenous drug users. Adverse effects were noted in 73% of those initially enrolled in this study, leading to discontinuation for 38%. No association was noted between pyrimethamine levels and the incidence of adverse events. No significant differences were seen in zidovudine pharmacokinetic parameters obtained from studies performed before and during treatment with pyrimethamine. In summary, pyrimethamine exhibited pharmacokinetics in HIV-infected patients that were similar to those in non-HIV-infected subjects and it did not alter the pharmacokinetics of zidovudine in these patients." @default.
• W2096100859 created "2016-06-24" @default.
• W2096100859 creator A5006102391 @default.
• W2096100859 creator A5020131744 @default.
• W2096100859 creator A5023959197 @default.
• W2096100859 creator A5048198586 @default.
• W2096100859 creator A5081855023 @default.
• W2096100859 creator A5083660592 @default.
• W2096100859 date "1996-06-01" @default.
• W2096100859 modified "2023-10-10" @default.
• W2096100859 title "Pyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for Toxoplasma gondii" @default.
• W2096100859 cites W12722936 @default.
• W2096100859 cites W1514983074 @default.
• W2096100859 cites W1963535021 @default.
• W2096100859 cites W1979485830 @default.
• W2096100859 cites W1985874427 @default.
• W2096100859 cites W2019145306 @default.
• W2096100859 cites W2043487102 @default.
• W2096100859 cites W2070914270 @default.
• W2096100859 cites W2079928834 @default.
• W2096100859 cites W2088421586 @default.
• W2096100859 cites W2145434855 @default.
• W2096100859 cites W2172059856 @default.
• W2096100859 cites W23163369 @default.
• W2096100859 cites W2324338583 @default.
• W2096100859 cites W2326870759 @default.
• W2096100859 cites W2417098255 @default.
• W2096100859 cites W3025190738 @default.
• W2096100859 doi "https://doi.org/10.1128/aac.40.6.1360" @default.
• W2096100859 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/163331" @default.
• W2096100859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8726001" @default.
• W2096100859 hasPublicationYear "1996" @default.
• W2096100859 type Work @default.
• W2096100859 sameAs 2096100859 @default.
• W2096100859 citedByCount "29" @default.
• W2096100859 countsByYear W20961008592012 @default.
• W2096100859 countsByYear W20961008592013 @default.
• W2096100859 countsByYear W20961008592014 @default.
• W2096100859 countsByYear W20961008592015 @default.
• W2096100859 countsByYear W20961008592016 @default.
• W2096100859 countsByYear W20961008592017 @default.
• W2096100859 countsByYear W20961008592018 @default.
• W2096100859 countsByYear W20961008592019 @default.
• W2096100859 countsByYear W20961008592020 @default.
• W2096100859 countsByYear W20961008592021 @default.
• W2096100859 countsByYear W20961008592022 @default.
• W2096100859 countsByYear W20961008592023 @default.
• W2096100859 crossrefType "journal-article" @default.
• W2096100859 hasAuthorship W2096100859A5006102391 @default.
• W2096100859 hasAuthorship W2096100859A5020131744 @default.
• W2096100859 hasAuthorship W2096100859A5023959197 @default.
• W2096100859 hasAuthorship W2096100859A5048198586 @default.
• W2096100859 hasAuthorship W2096100859A5081855023 @default.
• W2096100859 hasAuthorship W2096100859A5083660592 @default.
• W2096100859 hasBestOaLocation W20961008591 @default.
• W2096100859 hasConcept C112705442 @default.
• W2096100859 hasConcept C126322002 @default.
• W2096100859 hasConcept C139254425 @default.
• W2096100859 hasConcept C159047783 @default.
• W2096100859 hasConcept C192670549 @default.
• W2096100859 hasConcept C197934379 @default.
• W2096100859 hasConcept C203014093 @default.
• W2096100859 hasConcept C2777035104 @default.
• W2096100859 hasConcept C2777425658 @default.
• W2096100859 hasConcept C2778048844 @default.
• W2096100859 hasConcept C2778715236 @default.
• W2096100859 hasConcept C2780216070 @default.
• W2096100859 hasConcept C2780727368 @default.
• W2096100859 hasConcept C2908647359 @default.
• W2096100859 hasConcept C3013748606 @default.
• W2096100859 hasConcept C71924100 @default.
• W2096100859 hasConcept C98274493 @default.
• W2096100859 hasConcept C99454951 @default.
• W2096100859 hasConceptScore W2096100859C112705442 @default.
• W2096100859 hasConceptScore W2096100859C126322002 @default.
• W2096100859 hasConceptScore W2096100859C139254425 @default.
• W2096100859 hasConceptScore W2096100859C159047783 @default.
• W2096100859 hasConceptScore W2096100859C192670549 @default.
• W2096100859 hasConceptScore W2096100859C197934379 @default.
• W2096100859 hasConceptScore W2096100859C203014093 @default.
• W2096100859 hasConceptScore W2096100859C2777035104 @default.
• W2096100859 hasConceptScore W2096100859C2777425658 @default.
• W2096100859 hasConceptScore W2096100859C2778048844 @default.
• W2096100859 hasConceptScore W2096100859C2778715236 @default.
• W2096100859 hasConceptScore W2096100859C2780216070 @default.
• W2096100859 hasConceptScore W2096100859C2780727368 @default.
• W2096100859 hasConceptScore W2096100859C2908647359 @default.
• W2096100859 hasConceptScore W2096100859C3013748606 @default.
• W2096100859 hasConceptScore W2096100859C71924100 @default.
• W2096100859 hasConceptScore W2096100859C98274493 @default.
• W2096100859 hasConceptScore W2096100859C99454951 @default.
• W2096100859 hasIssue "6" @default.
• W2096100859 hasLocation W20961008591 @default.
• W2096100859 hasLocation W20961008592 @default.
• W2096100859 hasLocation W20961008593 @default.
• W2096100859 hasLocation W20961008594 @default.
• W2096100859 hasOpenAccess W2096100859 @default.
• W2096100859 hasPrimaryLocation W20961008591 @default.

• next